000			01944 a2200565 4500
005			20250517171420.0
264		0	_c20180409
008			201804s 0 0 eng d
022			_a1743-422X
024	7		_a10.1186/s12985-017-0826-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aYu, Jung Hwan
245	0	0	_aReal-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C. _h[electronic resource]
260			_bVirology journal _c08 2017
300			_a164 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aBase Sequence
650	0	4	_aCarbamates
650	0	4	_aDrug Combinations
650	0	4	_aDrug Resistance, Viral _xdrug effects
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xclassification
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xtherapeutic use
650	0	4	_aInterferons _xtherapeutic use
650	0	4	_aIsoquinolines _xtherapeutic use
650	0	4	_aLiver Cirrhosis _xvirology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrevalence
650	0	4	_aPyrrolidines
650	0	4	_aRNA, Viral _xisolation & purification
650	0	4	_aRepublic of Korea
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aSustained Virologic Response
650	0	4	_aTreatment Failure
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aViral Nonstructural Proteins _xdrug effects
700	1		_aLee, Jung Il
700	1		_aLee, Kwan Sik
700	1		_aKim, Ja Kyung
773	0		_tVirology journal _gvol. 14 _gno. 1 _gp. 164
856	4	0	_uhttps://doi.org/10.1186/s12985-017-0826-1 _zAvailable from publisher's website
999			_c27493903 _d27493903